digestive tolerance
Showing 1 - 25 of 6,387
Genetic Predisposition, Metabolic Diseases, Type 2 Diabetes Trial (Mixed Meal Tolerance Test (MMTT), Rybelsus)
Not yet recruiting
- Genetic Predisposition
- +2 more
- Mixed Meal Tolerance Test (MMTT)
- Rybelsus
- (no location specified)
Aug 18, 2023
Gestational Diabetes, Diagnoses Disease, Pregnancy in Diabetic Trial in Stanford (Fasting before gestational diabetes screen,
Completed
- Gestational Diabetes
- +3 more
- Fasting before gestational diabetes screen
- Per oral intake of food and drink
-
Stanford, CaliforniaStanford University
Oct 26, 2022
Diabetes, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) Trial in San Antonio (Dapagliflozin,
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Dapagliflozin
- +3 more
-
San Antonio, TexasThe University of Texas Health Science Center at San Antonio
Aug 29, 2022
type1diabetes, Obesity Trial in New Haven (Hyperinsulinemic-euglycemic clamp, High Fat Mixed Meal Tolerance Test)
Not yet recruiting
- type1diabetes
- Obesity
- Hyperinsulinemic-euglycemic clamp
- High Fat Mixed Meal Tolerance Test
-
New Haven, ConnecticutYale Pediatric Diabetes Research
Oct 23, 2023
Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in Beijing (Q-1802 Injection,Oxaliplatin Injection,Capecitabine)
Recruiting
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Q-1802 Injection,Oxaliplatin Injection,Capecitabine
-
Beijing, Beijing, ChinaBeijing cancer hospical
Jul 27, 2023
Obesity Trial in Nashville (Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline)
Active, not recruiting
- Obesity
- Oral Glucose Tolerance Test (OGTT)
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 18, 2022
Pre-diabetes, Obesity Trial in Lexington (Mirabegron 50 MG, Tadalafil 10 MG, Placebo)
Recruiting
- Pre-diabetes
- Obesity
- Mirabegron 50 MG
- +2 more
-
Lexington, KentuckyUniversity of Kentucky
Dec 13, 2021
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
Active, not recruiting
- IGT - Impaired Glucose Tolerance
- T2D
- Oral Glucose Tolerance Test
- +3 more
-
New Haven, ConnecticutYale University
Feb 8, 2022
PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo
Recruiting
- PreDiabetes
- +3 more
- Sacubitril-Valsartan Tab 97-103 MG
- +2 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Jul 21, 2022
Glucose Tolerance Trial in New York (Tyrosine (TYR) Supplementation)
Completed
- Glucose Tolerance
- Tyrosine (TYR) Supplementation
-
New York, New YorkColumbia University Irving Medical Center
Apr 30, 2021
Type 2 Diabetes, Impaired Glucose Tolerance, Non-Alcoholic Fatty Liver Disease Trial (Semaglutide Pen Injector, Placebo)
Not yet recruiting
- Type 2 Diabetes Mellitus
- +3 more
- Semaglutide Pen Injector
- Placebo
- (no location specified)
Jul 27, 2022
Obesity, Type 2 Diabetes Trial in New Haven (Oral Glucose tolerance test)
Recruiting
- Obesity
- Type 2 Diabetes
- Oral Glucose tolerance test
-
New Haven, ConnecticutYale University
Sep 2, 2021
PreDiabetes, Hyperglycemia, Glucose, High Blood Trial in Baltimore, Reading (Digital Diabetes Prevention Program (dDPP), Human
Recruiting
- PreDiabetes
- +10 more
- Digital Diabetes Prevention Program (dDPP)
- Human Coach-based Diabetes Prevention Program (hDPP)
-
Baltimore, Maryland
- +1 more
Mar 28, 2022
Nutrition, Health, Dietary Habits Trial in United States (Diet A, Diet B, Diet C)
Not yet recruiting
- Nutrition
- +2 more
- Diet A
- +4 more
-
Birmingham, Alabama
- +12 more
Jan 31, 2023
Immunosuppression, Kidney Transplantation, Graft Rejection Trial in Chicago (Infusion of Donor Hematopoietic Stem Cells and
Active, not recruiting
- Immunosuppression
- +2 more
- Infusion of Donor Hematopoietic Stem Cells and Campath-1H
-
Chicago, IllinoisNorthwestern Memorial Hospital
May 22, 2020
Healthy Trial in Barcelona, Madrid, Sevilla (Nutribén Innova® 1, Nutribén®, Breastfeed)
Completed
- Healthy
- Nutribén Innova® 1
- +2 more
-
Barcelona, Spain
- +20 more
Mar 30, 2022
Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)
Not yet recruiting
- Digestive Tumor
- TM4SF1-positive chimeric antigen receptor T-cell therapy
- (no location specified)
Dec 21, 2022
Anorexia Nervosa Trial in Málaga (Experimental Treatment, Oligomeric nutritional formula, Control Treatment)
Active, not recruiting
- Anorexia Nervosa
- Experimental Treatment, Oligomeric nutritional formula
- Control Treatment
-
Málaga, Malaga, SpainHospital Regional Universitario de Málaga
Jul 1, 2022
Esophageal Squamous Cell Carcinoma Trial in China (1% Lugol's iodine solution, 5% Lugol's iodine solution)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- 1% Lugol's iodine solution
- 5% Lugol's iodine solution
-
Ankang, Shaanxi, China
- +5 more
Sep 25, 2023
Abdominal Pain Trial (Bioactive hydrolysate)
Completed
- Abdominal Pain
- Bioactive hydrolysate
- (no location specified)
Apr 6, 2022
Gastrointestinal Disease, Flatulence, Gastrointestinal Tolerance Trial (Chilean Native Beans)
Unknown status
- Gastrointestinal Disease
- +4 more
- Chilean Native Beans
- (no location specified)
Jan 23, 2020
Malnutrition Trial in Lille, Nice (Sondalis® HP 2 kcal (with or without fibre))
Not yet recruiting
- Malnutrition
- Sondalis® HP 2 kcal (with or without fibre)
-
Lille, France
- +1 more
Jun 20, 2022
Preterm Birth, Enterocolitis, Necrotizing Trial in Paris (laparotomy, Laparoscopy)
Not yet recruiting
- Preterm Birth
- Enterocolitis, Necrotizing
- laparotomy
- Laparoscopy
-
Paris, France
- +1 more
May 26, 2023
Bariatric Surgery Candidate Trial (Potato starch)
Not yet recruiting
- Bariatric Surgery Candidate
- Potato starch
- (no location specified)
Dec 14, 2022
Digestive Health, Gastrointestinal Health Trial in Urbana (Placebo + Meal, BC-006 + Meal)
Recruiting
- Digestive Health
- Gastrointestinal Health
- Placebo + Meal
- BC-006 + Meal
-
Urbana, IllinoisFreer Hall
Jul 18, 2022